Nab-paclitaxel in older patients with non-small cell lung cancer who have developed disease progression after platinum-based doublet chemotherapy

Weiss, JM; Pennell, N; Deal, AM; Morgenzstern, D; Bradford, DS; Crane, J; West, HJ; Lee, C; Pecot, C; Stevenson, JP; Irvin, W; Socinski, M; Stinchcombe, T; Villaruz, LC; Muss, HB

CANCER, 2020; 126 (5): 1060